Last updated on November 2019

Study of Mirogabalin for Central Neuropathic Pain


Brief description of study

Investigate the efficacy and safety of mirogabalin in participants with central neuropathic pain in comparison to placebo

Detailed Study Description

[Double Blind Phase] The primary objective is to compare change in the Average Daily Pain Score (ADPS) from baseline to Week 14 in Asian participants with central neuropathic pain (central neuropathic pain after spinal cord injury) receiving mirogabalin versus placebo.

[Open Extension Phase] The objective is to assess the long-term safety and efficacy of mirogabalin in participants with central neuropathic pain (central neuropathic pain after spinal cord injury, central post stroke pain, and central neuropathic pain in Parkinson's disease).

Clinical Study Identifier: NCT03901352

Find a site near you

Start Over